
🇫🇷 living in Boston, immunologist, scientific advisor @broadinstitute. Former @CellCellPress & @TrendsImmuno editor. Opinions are my own.
Cambridge, MA
Joined March 2019
- Tweets23
- Following47
- Followers110
- Likes15
Jacques Deguine retweeted
Happy birthday @ImmunityCP ! Check out the special issue for their 25th anniversary here : cell.com/immunity/issue?pii=… and a cover made from 100+ labs in the #ImmunityCommunity
Jacques Deguine retweeted
—OK, I'd like an atlas of breast #cancer at the single-cell level, including the immune system
—No problem. Here it is. Nothing to it ;-)
(just 194 patient samples, 26 million single cells)
cell.com/cell/fulltext/S0092… @CellCellPress @CellPressNews by @BodenmillerLab
Jacques Deguine retweeted
What a beautiful and inspiring article ! A mandatory read to young and older scientists. I have rarely felt so aligned with an opinion piece ! Congrats Ron for your price and thank you for the inspiration ! cell.com/cell/fulltext/S0092…
The new smart cars at #AACR19 : Sadelain, Lim highlight current thinking of improving CAR-T #immunotherapy, by targeting with 2 distinct CAR (nature.com/articles/s41586-0…) or building dual or triple antigen sensors (with this strat : sciencedirect.com/science/ar… )
Important session to open day 4 of #AACR19 : addressing diversity in cancer : great talk by Melissa Davis @WeillCornell on the epidemiology of #breastcancer in US/Africa + role of a DARC allele prevalent in African ancestry in susceptibility
Want to discuss your work and publishing? Join Cell Press editors at #AACR19 booth 3128 at 3pm today
.@EJohnWherry at #AACR19 on exhausted T cells : functionally limited, but definitely still functional!
They proliferate and shape the stalemate with the tumor. Understanding their reinvigoration after anti-PD-1, and how to maintain high immune activity long term
Another important point: there is often a single peak of reinvigoration after PD-1 blockade, within a few weeks, suggesting that combinations need to be tested early in the treatment course #AACR19
2
2nd #AACR2019 session of the day, different part of the tumor environment -> M.Vander Heiden on critical role of local metabolite availability (more than metabolic pathway mutation) in shaping cancer cells. Check the preprint : biorxiv.org/content/10.1101/…
Jerome Galon starts D2 of #AACR2019 discussing the role of immune system in cancer prognosis and evolution. More in his recent @CellCellPress on analysis of metastases (cancer + immune infiltrate) over years cell.com/cell/fulltext/S0092…
3
Great talk by @dralexswarbrick on different methods for expanding single cell RNAseq by getting information on surface markers (CITE-seq) and fully sequencing some genes (such as TCRs or BCRs -> preprint here : biorxiv.org/content/10.1101/… )
#AACR2019 kicks off with education sessions! Great talks by Ami Bhatt and Elizabeth Hohmann highlight both the importance of #microbiome in therapy, how to measure microbial changes, and how to modulate it building on tools built for C.diff infection
Jen Wargo opens last #KScancerimm session on the power of the microbiome : within the tumor, and in the gut, bacteria affects responses to both targeted therapy and #Immunotherapy . Check her recent review on these 2 aspects : cell.com/trends/immunology/f…
Improving #immunotherapy : tonight's #KScancerimm session focused on combinations starts with Sandra Demaria, focused on radiotherapy + checkpoint blockade.
Her recent rev on the topic : cell.com/trends/immunology/f…
1
1
Great to see the translation in humans, here with CTLA4 blockade and radiation in lung cancer : nature.com/articles/s41591-0…
2nd day of #KScancerimm : great talk by Aviv Regev on resistance to immunotherapy in melanoma, dependent on a cancer cell instrisic program, that can be targeted with CDK inhibitors, read more about the work here: cell.com/cell/pdf/S0092-8674…
1
#KScancerimm Deciphering the tumor microenvironment : M.Angelo on the use of ion beam imaging to understand the #breastcancer TME, understanding both localization and expression is critical for prognostic
cell.com/cell/fulltext/S0092…
A holistic view of anti-tumor immune responses : R.Schreiber on the evidence for responses across lymphoid and myeloid compartments in recent @CellCellPress paper sciencedirect.com/science/ar… #KScancerimm
1
2
Importantly, achieving these broad responses will likely require targeting both CD8 and CD4 T cells, even though class II has been less of a focus, there is evidence for its role in cancer editing, and prediction tools are improving rapidly
cell.com/cell/fulltext/S0092…
1









